AAAAAA
Results:
1-23
|
Results: 23
Authors:
DOUGLASS HO
Citation: Ho. Douglass, ADJUVANT THERAPY FOR RECTAL-CANCER - RESULTS AND CONTROVERSIES - MINSKY ARTICLE REVIEWED, Oncology, 12(8), 1998, pp. 1144
Authors:
MAIBENCO DC
SMITH JL
NAVA HR
PETRELLI NJ
DOUGLASS HO
Citation: Dc. Maibenco et al., CARCINOMA OF THE GALLBLADDER, Cancer investigation, 16(1), 1998, pp. 33-39
Authors:
SMITH TJ
RYAN LM
DOUGLASS HO
HALLER DG
DAYAL Y
KIRKWOOD J
TORMEY DC
SCHUTT AJ
HINSON J
SISCHY B
Citation: Tj. Smith et al., COMBINED CHEMORADIOTHERAPY VS. RADIOTHERAPY ALONE FOR EARLY-STAGE SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, International journal of radiation oncology, biology, physics, 42(2), 1998, pp. 269-276
Authors:
DOUGLASS HO
Citation: Ho. Douglass, EFFECT OF LYMPH-NODE DISSECTION ON SURVIVAL OF GASTRIC-CARCINOMA, Journal of the American College of Surgeons, 184(6), 1997, pp. 667-668
Authors:
LEE JS
DOUGLASS HO
Citation: Js. Lee et Ho. Douglass, D2 DISSECTION FOR GASTRIC-CANCER, Surgical oncology, 6(4), 1997, pp. 215-225
Authors:
VAUGHN DJ
MEROPOL NJ
HOLROYDE C
MINTZER D
NUAMAH I
ARMSTEAD B
DOUGLASS HO
HALLER DG
Citation: Dj. Vaughn et al., A PHASE-II STUDY OF 5-FLUOROURACIL, LEUCOVORIN, ADRIAMYCIN, AND CISPLATIN (FLAP) FOR METASTATIC GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA - A PENN CANCER CLINICAL-TRIAL GROUP AND ROSWELL PARK CANCERINSTITUTE COMMUNITY ONCOLOGY RESEARCH-PROGRAM TRIAL, American journal of clinical oncology, 20(3), 1997, pp. 242-246
Authors:
VOLPE CM
DRISCOLL DL
MILORO SM
DOUGLASS HO
Citation: Cm. Volpe et al., SURVIVAL BENEFIT OF EXTENDED D2 RESECTION FOR PROXIMAL GASTRIC-CANCER, Journal of surgical oncology, 64(3), 1997, pp. 231-236
Authors:
DOUGLASS HO
SMITH JL
Citation: Ho. Douglass et Jl. Smith, UNTITLED, Journal of the American College of Surgeons, 183(3), 1996, pp. 291-292
Authors:
DOUGLASS HO
Citation: Ho. Douglass, ADJUVANT AND NEOADJUVANT THERAPY IN PANCREATIC-CANCER, The Cancer journal, 9(5), 1996, pp. 219-220
Authors:
MEROPOL NJ
PAZDUR R
VINCENT M
WILLSON JKV
KELSEN DP
DOUGLASS HO
Citation: Nj. Meropol et al., PHASE-II STUDY OF ZD-1694 IN PATIENTS WITH ADVANCED GASTRIC-CANCER, American journal of clinical oncology, 19(6), 1996, pp. 628-630
Authors:
VOLPE CM
DOUGLASS HO
Citation: Cm. Volpe et Ho. Douglass, PROXIMAL GASTRIC-CANCER AND EXTENDED RESECTION, Gastroenterology, 110(4), 1996, pp. 1425-1425
Authors:
DOUGLASS HO
Citation: Ho. Douglass, LOCAL RESECTION OF EARLY GASTRIC-CARCINOMA, Cancer, 77(4), 1996, pp. 597-598
Authors:
MEROPOL NJ
PETRELLI NJ
LIPMAN BJ
RODRIGUEZBIGAS M
HICKS W
DOUGLASS HO
SMITH JL
RASEY M
BLUMENSON LE
VAICKUS L
HAYES FA
AGOSTI JM
Citation: Nj. Meropol et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS INFECTION PROPHYLAXIS IN HIGH-RISK ONCOLOGIC SURGERY, The American journal of surgery, 172(3), 1996, pp. 299-302
Authors:
VOLPE CM
KOO JH
MILORO SM
DRISCOLL DL
NAVA HR
DOUGLASS HO
Citation: Cm. Volpe et al., THE EFFECT OF EXTENDED LYMPHADENECTOMY ON SURVIVAL IN PATIENTS WITH GASTRIC ADENOCARCINOMA, Journal of the American College of Surgeons, 181(1), 1995, pp. 56-64
Authors:
DOUGLASS HO
Citation: Ho. Douglass, ADJUVANT THERAPY FOR PANCREATIC-CANCER, World journal of surgery, 19(2), 1995, pp. 270-274
Authors:
CLARK JL
KUCUK O
NEUBERG DS
BENSON AB
TAYLOR SG
PANDYA KJ
MANSOUR EG
DOUGLASS HO
HALLER DG
Citation: Jl. Clark et al., PHASE-II TRIAL OF ETOPOSIDE, DOXORUBICIN, AND CISPLATIN COMBINATION IN ADVANCED MEASURABLE GASTRIC-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(4), 1995, pp. 318-324
Authors:
MOESTA KT
SCHLAG P
DOUGLASS HO
MANG TS
Citation: Kt. Moesta et al., EVALUATING THE ROLE OF PHOTODYNAMIC THERAPY IN THE MANAGEMENT OF PANCREATIC-CANCER, Lasers in surgery and medicine, 16(1), 1995, pp. 84-92
Authors:
PAZDUR R
MEROPOL NJ
CASPER ES
FUCHS C
DOUGLASS HO
VINCENT M
ABBRUZZESE JL
Citation: R. Pazdur et al., PHASE-II TRIAL OF ZD1694 (TOMUDEX(TM)) IN PATIENTS WITH ADVANCED PANCREATIC-CANCER, Investigational new drugs, 13(4), 1995, pp. 355-358
Authors:
STEIN BN
PETRELLI NJ
DOUGLASS HO
DRISCOLL DL
ARCANGELI G
MEROPOL NJ
Citation: Bn. Stein et al., AGE AND SEX ARE INDEPENDENT PREDICTORS OF 5-FLUOROURASIL TOXICITY - ANALYSIS OF A LARGE-SCALE PHASE-III TRIAL, Cancer, 75(1), 1995, pp. 11-17
Authors:
BAUER RL
PALMER ML
BAUER AM
NAVA HR
DOUGLASS HO
Citation: Rl. Bauer et al., ADENOCARCINOMA OF THE SMALL-INTESTINE - 21-YEAR REVIEW OF DIAGNOSIS, TREATMENT, AND PROGNOSIS, Annals of surgical oncology, 1(3), 1994, pp. 183-188
Authors:
DOUGLASS HO
Citation: Ho. Douglass, ADJUVANT THERAPY OF GASTRIC-CANCER - HAVE WE MADE ANY PROGRESS, Annals of oncology, 5, 1994, pp. 190000049-190000057
Authors:
DOUGLASS HO
Citation: Ho. Douglass, CURRENT APPROACHES TO MULTIMODALITY MANAGEMENT OF ADVANCED PANCREATIC-CANCER, Hepato-gastroenterology, 40(5), 1993, pp. 433-442
Authors:
WOOLLEY PV
NAUTA R
SMITH FP
LINDBLAD AS
PETRELLI N
HERRERA L
DOUGLASS HO
MAYER RJ
BRUCKNER HW
DALTON J
BONADONNA G
GENNARI L
HALL TC
WEAVER DW
LEICHMAN L
KALSER MH
BENEDETTO P
MUGGIA FM
GREEN M
GREENWALD E
LEVIN B
GAYNOR E
HARRIS J
MARSH JC
BARWICK K
KNOWLTON AH
LIVSTONE EM
BUKOWSKI RM
LOUTFI A
RAMIREZ G
THOMAS PRM
Citation: Pv. Woolley et al., RADIATION-THERAPY AND FLUOROURACIL WITH OR WITHOUT SEMUSTINE FOR THE TREATMENT OF PATIENTS WITH SURGICAL ADJUVANT ADENOCARCINOMA OF THE RECTUM, Journal of clinical oncology, 10(4), 1992, pp. 549-557
Risultati:
1-23
|